Is 4DMedical Limited (FDMDF) a Buy, Sell, or Hold?
OTC : FDMDF
4DMedical Limited
$2.53 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 815
- Market Capitalization
- $1.52B
- P/E Ratio
- -10.58
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.00
- Year Low
- $0.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.57
Company Overview
OTC
Andreas Fouras
Medical - Devices
Healthcare
FDMDF
124
AU
USD
Liquidity Metrics
-0.23
6.57
6.48
5.87
0.00
Sales & Valuation
$5.85M
473.48
-59.68
-89.21
-0.05
Profitability
-$0.14
-$30.07M
-3684.62%
-3941.24%
-890.76%
-114.36%
P/E Metrics
-10.58
0.01
0.01
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
2.63
4/9
$53.88M
$139.49M
$167.89M
-$96.35M
Key Metrics (TTM)
$2.01B
463.24
-56.58
6.57
-890.76%
-37.27%
-9.39%
-1.12%
223 days
Company Executives
| Name | Title |
|---|---|
| Greg T. Mogel | Chief Medical Officer |
| Beth Plunkett | Senior Legal Counsel |
| David Hannes | Senior Vice President of Global Business Development |
| Rachael Tenkaten | Senior Vice President of Product |
| Julian Sutton | CFO & Executive Director |
| Aidan Jamison | Senior Vice President of Engineering |
| Andreas Fouras | Founder, MD, Chief Executive Officer & Director |
| Hamish George | Company Secretary |
| Matt Tucker | Chief Commercial Officer |
Poll Results
No votes yet today — be the first to share your view!
About 4DMedical Limited (OTC:FDMDF) Stock
4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia. ...
4DMedical Limited (FDMDF) M&A Call Transcript
2026-06-09 00:58:29
4DMedical Limited (FDMDF) M&A Call Transcript
2026-05-21 00:30:41
4DMedical Limited (FDMDF) Discusses Clinical Use of CT:VQ in Patient Selection for Lung Volume Reduction Surgery Transcript
Frequently Asked Questions
-
What is the current 4DMedical Limited (FDMDF) stock price?
-
4DMedical Limited(OTC:FDMDF) stock price is $2.53 in the last trading session. During the trading session, FDMDF stock reached the peak price of $5 while $0.1625 was the lowest point it dropped to. The percentage change in FDMDF stock occurred in the recent session was 0.0% while the dollar amount for the price change in FDMDF stock was $0.
-
FDMDF's industry and sector of operation?
-
The OTC listed FDMDF is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of FDMDF?
-
Greg T. Mogel | Chief Medical Officer
Beth Plunkett | Senior Legal Counsel
David Hannes | Senior Vice President of Global Business Development
Rachael Tenkaten | Senior Vice President of Product
Julian Sutton | CFO & Executive Director -
How many employees does FDMDF have?
-
Number of FDMDF employees currently stands at 124. FDMDF operates from Melbourne Connect, Carlton, VIC 3053, AU.
-
Link for FDMDF official website?
-
Official Website of FDMDF is: https://www.4dmedical.com
-
How do I contact FDMDF?
-
FDMDF could be contacted at phone #61 3 9545 5940 and can also be accessed through its website. FDMDF operates from Melbourne Connect, Carlton, VIC 3053, AU.
-
How many shares of FDMDF are traded daily?
-
The average number of FDMDF shares traded daily for last 3 months was 815.
-
What is the market cap of FDMDF currently?
-
The market value of FDMDF currently stands at $1.52B with its latest stock price at $2.53